Healthcare -
Medical - Diagnostics & Research - NYSE - US
$ 165.86
0.175 %
$ 8.48 B
Market Cap
20.68
P/E
CRL - TOTAL EQUITY
Total Equity CRL - Charles River Laboratories International, Inc.
3.66 B
LAST VALUE
18.81%
2 YEAR CAGR
22.28%
5 YEAR CAGR
18.60%
10 YEAR CAGR